PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic LeukemiaBritten Gordon, Jennifer A. Woyach, Jyotsna Singh et al.|Blood Cancer Discovery|2025Cited by 1